Rapal, Federico B.

HRN: 21-41-71  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2022
CEFTRIAXONE 1G (VIAL)
06/01/2022
06/08/2022
IVT
2 G
Once A Day
Community Acquired Pneumonia
Waiting Final Action 
06/02/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/02/2022
06/09/2022
IV
600mg
Q8
Aspiration Pneumonia
Waiting Final Action 
04/14/2023
CO-AMOXICLAV 625MG (TAB)
04/14/2023
04/20/2023
ORAL
625mg
Tid
Otitis Media, R Ear; CAP LR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: